Early detection of Alzheimer’s disease (AD) risk requires sensitive and specific biomarkers that can be reliably measured in blood. In this study, Roboscreen GmbH evaluated a novel Luminescence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results